Clinical phenotypes of very early onset inflammatory bowel disease in Australian children: A single-centre retrospective study.

Authors

Jonathan Dudzik, Peter Lewindon

Published in

Journal of pediatric gastroenterology and nutrition. Sep 22, 2026. Epub Sep 22, 2026.

Abstract

Very early onset inflammatory bowel disease (VEO-IBD), diagnosed at <6 years old, includes a subset of infantile onset IBD (IO-IBD, ≤2 years). We describe presenting clinical features, phenotypes, and early management of children with VEO-IBD at a single tertiary centre.
Retrospective cohort study of children with VEO-IBD diagnosed at Queensland Children's Hospital from January 2010 to March 2025.
In 52 children, (24 IO-IBD; 28 VEO-IBD), median Paediatric Ulcerative Colitis Activity Index on presentation was 35 (interquartile range [IQR] 15), similar in both groups (35 IO-IBD; 39.5 VEO-IBD). Ulcerative colitis (UC) was the most frequent diagnosis (50%; 38% Crohn's disease; 12% IBD-Unclassified [IBD-U]). Among children with UC/IBD-U, pancolitis was common in both groups (57.1% IO-IBD; 66.7% VEO-IBD). Paris-classified anatomic phenotype did not differ between IO-IBD and VEO-IBD. Atypical colitis, upper gastrointestinal involvement, and granulomas occurred in 23%, 38% and 35% of cases, respectively. Prior allergic/atopic diagnoses were documented in 44%. Primary sclerosing cholangitis (PSC) was identified in 8% within 12 months of IBD diagnosis. Two monogenic disorders were identified, among 38 genotyped children, with severe perianal disease and successful bone marrow transplantation. Corticosteroids were used in 67% (35/52); 86% (30/35) responded without biologic rescue; five required anti-tumour necrosis factor therapy. One child required early colectomy.
IO-IBD and VEO-IBD demonstrated substantial overlap in presenting clinical and intestinal phenotypes. Monogenic disease was confined to IO-IBD, while early PSC was a notable secondary finding. These data support phenotype-guided genetic evaluation and further study of early hepatobiliary disease in VEO-IBD.

PMID:
42768947
Bibliographic data and abstract were imported from PubMed on 22 Sep 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.